INFU InfuSystem Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: INFU

Price (delayed)

$12.67

Market cap

$252.35M

P/E Ratio

30.17

Dividend/share

N/A

EPS

$0.42

Enterprise value

$274.64M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 71
Relative Profitability: Rel. Profitability: 79

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided ...

Highlights
The company's EPS has surged by 83% YoY and by 11% QoQ
The company's net income has surged by 68% YoY and by 8% QoQ
The stock's price to earnings (P/E) is 86% less than its 5-year quarterly average of 223.3 but 5% more than its last 4 quarters average of 28.8
The debt has contracted by 24% YoY but it has grown by 2.1% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.infusystem.com
Peers: CRVL

Key stats

What are the main financial stats of INFU

INFU stock price

How has the InfuSystem Holdings stock price performed over time
Intraday
-0.24%
1 week
1.52%
1 month
6.03%
1 year
23.61%
YTD
41.25%
QTD
31.3%

Financial performance

How have InfuSystem Holdings's revenue and profit performed over time
Revenue
$143.34M
Gross profit
$82.35M
Operating income
$13.25M
Net income
$8.54M
Gross margin
57.5%
Net margin
6%
The company's net income has surged by 68% YoY and by 8% QoQ
The net margin has soared by 67% YoY and by 7% from the previous quarter
The operating income has grown by 28% YoY and by 2.9% from the previous quarter
The company's operating margin rose by 24% YoY and by 2.2% QoQ

Price vs fundamentals

How does INFU's price correlate with its fundamentals

Growth

What is InfuSystem Holdings's growth rate over time

Valuation

What is InfuSystem Holdings stock price valuation
INFU P/E details
P/E
30.17
P/B
4.32
P/S
1.77
EV/EBIT
20.63
EV/EBITDA
10.41
EV/Sales
1.92
The stock's price to earnings (P/E) is 86% less than its 5-year quarterly average of 223.3 but 5% more than its last 4 quarters average of 28.8
The company's EPS has surged by 83% YoY and by 11% QoQ
The stock's P/B is 27% above its last 4 quarters average of 3.4 and 17% above its 5-year quarterly average of 3.7
The equity rose by 8% YoY
INFU's P/S is 27% above its last 4 quarters average of 1.4 and 11% above its 5-year quarterly average of 1.6
InfuSystem Holdings's revenue has increased by 2.5% YoY

Efficiency

How efficient is InfuSystem Holdings business performance
The ROA has soared by 76% YoY and by 9% from the previous quarter
The ROE has soared by 63% YoY and by 6% from the previous quarter
INFU's return on invested capital has surged by 50% year-on-year and by 5% since the previous quarter
The company's return on sales rose by 26% YoY and by 2.2% QoQ

Dividends

What is INFU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INFU.

Financial health

How did InfuSystem Holdings financials performed over time
The total assets is 153% greater than the total liabilities
The quick ratio is up by 21% QoQ and by 16% YoY
The current ratio has grown by 17% from the previous quarter and by 14% YoY
The debt is 61% less than the equity
InfuSystem Holdings's debt to equity has decreased by 30% YoY
The debt has contracted by 24% YoY but it has grown by 2.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.